Mahendar Ochani Selected Research

4- hydroxybenzaldehyde- O- cyclohexanecarbonyloxime

8/2007

Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahendar Ochani Research Topics

Disease

28	Sepsis (Septicemia) 01/2021 - 09/2002
22	Inflammation (Inflammations) 12/2021 - 03/2002
13	Endotoxemia 03/2015 - 09/2002
7	Infections 01/2018 - 09/2002
5	Acute Lung Injury 01/2020 - 01/2003
3	Reperfusion Injury 01/2020 - 12/2002
3	Ischemia 01/2020 - 12/2002
3	Shock 12/2007 - 03/2002
2	Body Weight (Weight, Body) 01/2020 - 01/2011
2	Obesity 10/2012 - 01/2011
2	Necrosis 06/2010 - 01/2003
2	Anorexia 06/2010 - 01/2003
2	Fever (Fevers) 06/2010 - 08/2008
1	Mesenteric Ischemia 12/2021
1	Lung Injury 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Pneumonia (Pneumonitis) 10/2016
1	Alzheimer Disease (Alzheimer's Disease) 02/2015
1	Schizophrenia (Dementia Praecox) 02/2015
1	Cognitive Dysfunction 09/2012
1	Euthyroid Sick Syndromes (Euthyroid Sick Syndrome) 05/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Insulin Resistance 01/2011
1	Glucose Intolerance 01/2011
1	Hypotension (Low Blood Pressure) 08/2008

Drug/Important Bio-Agent (IBA)

22	CytokinesIBA 01/2020 - 09/2002
13	HMGB1 Protein (HMG1)IBA 09/2012 - 09/2002
8	Cholinergic Agents (Cholinergics)IBA 03/2015 - 03/2002
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007 - 03/2002
7	EndotoxinsIBA 01/2017 - 03/2002
5	Proteins (Proteins, Gene)FDA Link 02/2015 - 04/2003
4	AntibodiesIBA 01/2018 - 01/2003
4	alpha7 Nicotinic Acetylcholine ReceptorIBA 09/2008 - 01/2003
3	Peptides (Polypeptides)IBA 12/2020 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 03/2002
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 12/2020 - 01/2020
2	ChemokinesIBA 01/2020 - 07/2009
2	Interleukin-6 (Interleukin 6)IBA 10/2016 - 03/2015
2	Neutralizing AntibodiesIBA 10/2016 - 02/2015
2	OsteopontinIBA 10/2016 - 02/2015
2	Immunoglobulin G (IgG)IBA 10/2016 - 01/2004
2	Messenger RNA (mRNA)IBA 03/2015 - 02/2015
2	Macrophage Migration-Inhibitory FactorsIBA 05/2011 - 08/2007
2	Galantamine (Galanthamine)FDA LinkGeneric 01/2011 - 01/2009
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2008 - 08/2008
2	CaspasesIBA 09/2008 - 07/2006
2	Therapeutic UsesIBA 08/2007 - 04/2005
2	Nicotine FDA Link 07/2006 - 11/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2006 - 01/2004
1	Immunoglobulin M (IgM)IBA 12/2021
1	Interleukin-10 (Interleukin 10)IBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021
1	LigandsIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 12/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	Saline SolutionIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	GhrelinIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	Junctional Adhesion Molecule CIBA 12/2018
1	Connexin 43 (Connexin43)IBA 01/2018
1	TAT-Gap19 peptideIBA 01/2018
1	alpha-MSHIBA 01/2017
1	CateninsIBA 01/2017
1	Type 1 Melanocortin ReceptorIBA 01/2017
1	InterleukinsIBA 03/2015
1	xanomelineIBA 02/2015
1	pigment epithelium-derived factorIBA 10/2012
1	CarrageenanIBA 05/2011
1	Thyroid HormonesIBA 05/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	Blood Glucose (Blood Sugar)IBA 01/2011
1	AdipokinesIBA 01/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2010
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2009
1	AcetylcholinesteraseIBA 01/2009
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2009
1	Choline (Choline Chloride)IBA 09/2008
1	LipopolysaccharidesIBA 12/2007
1	4- hydroxybenzaldehyde- O- cyclohexanecarbonyloximeIBA 08/2007
1	Cholinergic ReceptorsIBA 04/2007
1	3-(2,4-dimethoxybenzylidene)anabaseineIBA 04/2007
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 07/2006
1	(4- (m- Chlorophenylcarbamoyloxy)- 2- butynyl)trimethylammonium ChlorideIBA 03/2006
1	methoctramineIBA 03/2006
1	MuscarineIBA 03/2006

Therapy/Procedure

13	Punctures 01/2021 - 11/2005
13	Ligation 01/2021 - 11/2005
5	Therapeutics 01/2017 - 01/2004
3	Vagus Nerve Stimulation 08/2008 - 07/2006
2	Splenectomy 09/2008 - 07/2006
2	Critical Care (Surgical Intensive Care) 02/2006 - 01/2004
1	Surgical Instruments (Clip) 12/2021